Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6425505 | 1.00 | ALDH1A1 (0.33) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL6378618 | 1.00 | ALDH1A1 (0.33) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL13082552 | 0.73 | ALDH1A1 (0.43) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL8423510 | 0.72 | ALDH1A1 (0.42) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL19112477 | 0.71 | ALDH1A1 (0.44) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL7708743 | 0.69 | ALDH1A1 (0.35) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL8776159 | 0.68 | ALDH1A1 (0.41) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL9356254 | 0.66 | ALDH1A1 (0.39) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 | |
| SCHEMBL5856784 | 0.65 | CYP2C9 (0.37) | ALDH1A1GAAMAPK1 | |
| SCHEMBL31611892 | 0.63 | ALDH1A1 (0.38) | ALDH1A1GAALMNAMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1157000-B1 | BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY | WARNER LAMBERT CO (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1157000-A1 | BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY | WARNER-LAMBERT COMPANY (US) | 2001-11-28 | — | — | EP | disclosed |
| WO-2001042191-A1 | BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY | WARNER-LAMBERT COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |